These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
KIMBALL INTERNATIONAL, INC.
|
(Exact name of registrant as specified in its charter)
|
Indiana
|
|
35-0514506
|
(State or other jurisdiction of
|
|
(I.R.S. Employer Identification No.)
|
incorporation or organization)
|
|
|
1600 Royal Street, Jasper, Indiana
|
|
47549-1001
|
(Address of principal executive offices)
|
|
(Zip Code)
|
(812) 482-1600
|
Registrant's telephone number, including area code
|
Not Applicable
|
Former name, former address and former fiscal year, if changed since last report
|
|
Page No.
|
|
|
|
|
|
|
PART I FINANCIAL INFORMATION
|
|
||
|
|
|
|
|
|
|
|
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
|
|
PART II OTHER INFORMATION
|
|
||
|
|
|
|
|
|
||
|
|
||
|
|
|
|
|
|||
|
|
|
|
|
|
(Unaudited)
|
|
|
|
|||
|
March 31,
2012 |
|
June 30,
2011 |
||||
ASSETS
|
|
|
|
|
|
||
Current Assets:
|
|
|
|
|
|
||
Cash and cash equivalents
|
$
|
54,467
|
|
|
$
|
51,409
|
|
Receivables, net of allowances of $1,584 and $1,799, respectively
|
143,858
|
|
|
149,753
|
|
||
Inventories
|
127,016
|
|
|
141,097
|
|
||
Prepaid expenses and other current assets
|
46,840
|
|
|
50,215
|
|
||
Assets held for sale
|
2,281
|
|
|
2,807
|
|
||
Total current assets
|
374,462
|
|
|
395,281
|
|
||
Property and Equipment, net of accumulated depreciation of $356,137 and $360,105, respectively
|
190,570
|
|
|
196,682
|
|
||
Goodwill
|
2,542
|
|
|
2,644
|
|
||
Other Intangible Assets, net of accumulated amortization of $65,773 and $65,514, respectively
|
6,871
|
|
|
7,625
|
|
||
Other Assets
|
22,303
|
|
|
24,080
|
|
||
Total Assets
|
$
|
596,748
|
|
|
$
|
626,312
|
|
|
|
|
|
||||
LIABILITIES AND SHARE OWNERS' EQUITY
|
|
|
|
||||
Current Liabilities:
|
|
|
|
||||
Current maturities of long-term debt
|
$
|
14
|
|
|
$
|
12
|
|
Accounts payable
|
140,248
|
|
|
149,107
|
|
||
Dividends payable
|
1,843
|
|
|
1,835
|
|
||
Accrued expenses
|
48,491
|
|
|
66,316
|
|
||
Total current liabilities
|
190,596
|
|
|
217,270
|
|
||
Other Liabilities:
|
|
|
|
||||
Long-term debt, less current maturities
|
273
|
|
|
286
|
|
||
Other
|
21,130
|
|
|
21,357
|
|
||
Total other liabilities
|
21,403
|
|
|
21,643
|
|
||
Share Owners' Equity:
|
|
|
|
||||
Common stock-par value $0.05 per share:
|
|
|
|
||||
Class A - 50,000,000 shares authorized; 14,368,000 shares issued
|
718
|
|
|
718
|
|
||
Class B - 100,000,000 shares authorized; 28,657,000 shares issued
|
1,433
|
|
|
1,433
|
|
||
Additional paid-in capital
|
170
|
|
|
230
|
|
||
Retained earnings
|
447,860
|
|
|
450,172
|
|
||
Accumulated other comprehensive income (loss)
|
(1,744
|
)
|
|
1,618
|
|
||
Less: Treasury stock, at cost:
|
|
|
|
||||
Class A - 4,020,000 and 3,945,000 shares, respectively
|
(49,235
|
)
|
|
(49,437
|
)
|
||
Class B - 1,104,000 and 1,330,000 shares, respectively
|
(14,453
|
)
|
|
(17,335
|
)
|
||
Total Share Owners' Equity
|
384,749
|
|
|
387,399
|
|
||
Total Liabilities and Share Owners' Equity
|
$
|
596,748
|
|
|
$
|
626,312
|
|
|
(Unaudited)
|
|
(Unaudited)
|
||||||||||||
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||
|
March 31
|
|
March 31
|
||||||||||||
|
2012
|
|
2011
|
|
2012
|
|
2011
|
||||||||
Net Sales
|
$
|
284,414
|
|
|
$
|
314,466
|
|
|
$
|
851,953
|
|
|
$
|
919,774
|
|
Cost of Sales
|
233,775
|
|
|
263,775
|
|
|
700,024
|
|
|
772,360
|
|
||||
Gross Profit
|
50,639
|
|
|
50,691
|
|
|
151,929
|
|
|
147,414
|
|
||||
Selling and Administrative Expenses
|
47,650
|
|
|
46,869
|
|
|
142,215
|
|
|
143,206
|
|
||||
Restructuring Expense
|
895
|
|
|
68
|
|
|
2,488
|
|
|
553
|
|
||||
Operating Income
|
2,094
|
|
|
3,754
|
|
|
7,226
|
|
|
3,655
|
|
||||
Other Income (Expense):
|
|
|
|
|
|
|
|
||||||||
Interest income
|
121
|
|
|
196
|
|
|
341
|
|
|
587
|
|
||||
Interest expense
|
(7
|
)
|
|
(40
|
)
|
|
(23
|
)
|
|
(110
|
)
|
||||
Non-operating income, net
|
1,054
|
|
|
745
|
|
|
1,090
|
|
|
1,411
|
|
||||
Other income, net
|
1,168
|
|
|
901
|
|
|
1,408
|
|
|
1,888
|
|
||||
Income Before Taxes on Income
|
3,262
|
|
|
4,655
|
|
|
8,634
|
|
|
5,543
|
|
||||
Provision for Income Taxes
|
756
|
|
|
1,349
|
|
|
3,077
|
|
|
905
|
|
||||
Net Income
|
$
|
2,506
|
|
|
$
|
3,306
|
|
|
$
|
5,557
|
|
|
$
|
4,638
|
|
|
|
|
|
|
|
|
|
||||||||
Earnings Per Share of Common Stock:
|
|
|
|
|
|
|
|
|
|
||||||
Basic Earnings Per Share:
|
|
|
|
|
|
|
|
|
|
||||||
Class A
|
$
|
0.06
|
|
|
$
|
0.08
|
|
|
$
|
0.14
|
|
|
$
|
0.11
|
|
Class B
|
$
|
0.07
|
|
|
$
|
0.09
|
|
|
$
|
0.15
|
|
|
$
|
0.13
|
|
Diluted Earnings Per Share:
|
|
|
|
|
|
|
|
||||||||
Class A
|
$
|
0.06
|
|
|
$
|
0.08
|
|
|
$
|
0.14
|
|
|
$
|
0.11
|
|
Class B
|
$
|
0.07
|
|
|
$
|
0.09
|
|
|
$
|
0.15
|
|
|
$
|
0.13
|
|
|
|
|
|
|
|
|
|
||||||||
Dividends Per Share of Common Stock:
|
|
|
|
|
|
|
|
||||||||
Class A
|
$
|
0.045
|
|
|
$
|
0.045
|
|
|
$
|
0.135
|
|
|
$
|
0.135
|
|
Class B
|
$
|
0.050
|
|
|
$
|
0.050
|
|
|
$
|
0.150
|
|
|
$
|
0.150
|
|
|
|
|
|
|
|
|
|
||||||||
Average Number of Shares Outstanding:
|
|
|
|
|
|
|
|
||||||||
Class A and B Common Stock:
|
|
|
|
|
|
|
|
||||||||
Basic
|
37,899
|
|
|
37,746
|
|
|
37,875
|
|
|
37,718
|
|
||||
Diluted
|
38,005
|
|
|
37,845
|
|
|
38,024
|
|
|
37,856
|
|
|
(Unaudited)
|
||||||
|
Nine Months Ended
|
||||||
|
March 31
|
||||||
|
2012
|
|
2011
|
||||
Cash Flows From Operating Activities:
|
|
|
|
||||
Net income
|
$
|
5,557
|
|
|
$
|
4,638
|
|
Adjustments to reconcile net income to net cash provided by (used for) operating activities:
|
|
|
|||||
Depreciation and amortization
|
23,036
|
|
|
23,509
|
|
||
(Gain) loss on sales of assets
|
6
|
|
|
(36
|
)
|
||
Restructuring
|
(167
|
)
|
|
—
|
|
||
Deferred income tax and other deferred charges
|
3,906
|
|
|
4,673
|
|
||
Stock-based compensation
|
960
|
|
|
1,049
|
|
||
Excess tax benefits from stock-based compensation
|
(42
|
)
|
|
—
|
|
||
Other, net
|
802
|
|
|
772
|
|
||
Change in operating assets and liabilities:
|
|
|
|
||||
Receivables
|
4,105
|
|
|
(31,557
|
)
|
||
Inventories
|
11,722
|
|
|
(2,642
|
)
|
||
Prepaid expenses and other current assets
|
3,217
|
|
|
(3,685
|
)
|
||
Accounts payable
|
(5,494
|
)
|
|
(9,195
|
)
|
||
Accrued expenses
|
(17,609
|
)
|
|
4,910
|
|
||
Net cash provided by (used for) operating activities
|
29,999
|
|
|
(7,564
|
)
|
||
Cash Flows From Investing Activities:
|
|
|
|
||||
Capital expenditures
|
(21,147
|
)
|
|
(20,893
|
)
|
||
Proceeds from sales of assets
|
2,282
|
|
|
888
|
|
||
Purchases of capitalized software
|
(1,049
|
)
|
|
(1,100
|
)
|
||
Other, net
|
129
|
|
|
(1,023
|
)
|
||
Net cash used for investing activities
|
(19,785
|
)
|
|
(22,128
|
)
|
||
Cash Flows From Financing Activities:
|
|
|
|
||||
Proceeds from revolving credit facility
|
—
|
|
|
82,300
|
|
||
Payments on revolving credit facility
|
—
|
|
|
(82,300
|
)
|
||
Additional net change in credit facilities
|
—
|
|
|
5,900
|
|
||
Payments on long-term debt
|
(11
|
)
|
|
(12
|
)
|
||
Dividends paid to Share Owners
|
(5,520
|
)
|
|
(5,495
|
)
|
||
Excess tax benefits from stock-based compensation
|
42
|
|
|
—
|
|
||
Repurchase of employee shares for tax withholding
|
(337
|
)
|
|
(278
|
)
|
||
Net cash (used for) provided by financing activities
|
(5,826
|
)
|
|
115
|
|
||
Effect of Exchange Rate Change on Cash and Cash Equivalents
|
(1,330
|
)
|
|
5,487
|
|
||
Net Increase (Decrease) in Cash and Cash Equivalents
|
3,058
|
|
|
(24,090
|
)
|
||
Cash and Cash Equivalents at Beginning of Period
|
51,409
|
|
|
65,342
|
|
||
Cash and Cash Equivalents at End of Period
|
$
|
54,467
|
|
|
$
|
41,252
|
|
Supplemental Disclosure of Cash Flow Information
|
|
|
|
||||
Cash paid during the period for:
|
|
|
|
||||
Income taxes
|
$
|
1,426
|
|
|
$
|
215
|
|
Interest expense
|
$
|
32
|
|
|
$
|
106
|
|
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||
|
March 31
|
|
March 31
|
||||||||||||
(Amounts in Thousands)
|
2012
|
|
2011
|
|
2012
|
|
2011
|
||||||||
Foreign Currency/Derivative Gain (Loss)
|
$
|
(283
|
)
|
|
$
|
100
|
|
|
$
|
828
|
|
|
$
|
(1,271
|
)
|
Gain on Supplemental Employee Retirement Plan Investments
|
1,370
|
|
|
690
|
|
|
495
|
|
|
2,966
|
|
||||
Other
|
(33
|
)
|
|
(45
|
)
|
|
(233
|
)
|
|
(284
|
)
|
||||
Non-operating income, net
|
$
|
1,054
|
|
|
$
|
745
|
|
|
$
|
1,090
|
|
|
$
|
1,411
|
|
(Amounts in Thousands)
|
March 31, 2012
|
|
June 30,
2011 |
||||
Finished products
|
$
|
29,859
|
|
|
$
|
33,287
|
|
Work-in-process
|
11,748
|
|
|
11,734
|
|
||
Raw materials
|
99,893
|
|
|
109,337
|
|
||
Total FIFO inventory
|
$
|
141,500
|
|
|
$
|
154,358
|
|
LIFO reserve
|
(14,484
|
)
|
|
(13,261
|
)
|
||
Total inventory
|
$
|
127,016
|
|
|
$
|
141,097
|
|
|
Three Months Ended
|
|
Three Months Ended
|
||||||||||||||||||||
|
March 31, 2012
|
|
March 31, 2011
|
||||||||||||||||||||
(Amounts in Thousands)
|
Pre-tax
|
|
Tax
|
|
Net of Tax
|
|
Pre-tax
|
|
Tax
|
|
Net of Tax
|
||||||||||||
Net income
|
|
|
|
|
|
|
$
|
2,506
|
|
|
|
|
|
|
|
|
$
|
3,306
|
|
||||
Other comprehensive income (loss):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Foreign currency translation adjustments
|
$
|
2,134
|
|
|
$
|
(130
|
)
|
|
$
|
2,004
|
|
|
$
|
4,765
|
|
|
$
|
(1,090
|
)
|
|
$
|
3,675
|
|
Postemployment severance actuarial change
|
168
|
|
|
(68
|
)
|
|
100
|
|
|
620
|
|
|
(247
|
)
|
|
373
|
|
||||||
Derivative gain (loss)
|
1,697
|
|
|
(527
|
)
|
|
1,170
|
|
|
(337
|
)
|
|
(54
|
)
|
|
(391
|
)
|
||||||
Reclassification to (earnings) loss:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Derivatives
|
236
|
|
|
(78
|
)
|
|
158
|
|
|
(408
|
)
|
|
136
|
|
|
(272
|
)
|
||||||
Amortization of prior service costs
|
71
|
|
|
(28
|
)
|
|
43
|
|
|
71
|
|
|
(28
|
)
|
|
43
|
|
||||||
Amortization of actuarial change
|
20
|
|
|
(7
|
)
|
|
13
|
|
|
183
|
|
|
(73
|
)
|
|
110
|
|
||||||
Other comprehensive income
|
$
|
4,326
|
|
|
$
|
(838
|
)
|
|
$
|
3,488
|
|
|
$
|
4,894
|
|
|
$
|
(1,356
|
)
|
|
$
|
3,538
|
|
Comprehensive income
|
|
|
|
|
|
|
$
|
5,994
|
|
|
|
|
|
|
|
|
$
|
6,844
|
|
|
Nine Months Ended
|
|
Nine Months Ended
|
||||||||||||||||||||
|
March 31, 2012
|
|
March 31, 2011
|
||||||||||||||||||||
(Amounts in Thousands)
|
Pre-tax
|
|
Tax
|
|
Net of Tax
|
|
Pre-tax
|
|
Tax
|
|
Net of Tax
|
||||||||||||
Net income
|
|
|
|
|
|
|
$
|
5,557
|
|
|
|
|
|
|
|
|
$
|
4,638
|
|
||||
Other comprehensive income (loss):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Foreign currency translation adjustments
|
$
|
(6,391
|
)
|
|
$
|
1,886
|
|
|
$
|
(4,505
|
)
|
|
$
|
11,543
|
|
|
$
|
(2,652
|
)
|
|
$
|
8,891
|
|
Postemployment severance actuarial change
|
1,195
|
|
|
(477
|
)
|
|
718
|
|
|
1,107
|
|
|
(442
|
)
|
|
665
|
|
||||||
Derivative gain (loss)
|
(503
|
)
|
|
292
|
|
|
(211
|
)
|
|
839
|
|
|
(375
|
)
|
|
464
|
|
||||||
Reclassification to (earnings) loss:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Foreign currency translation adjustments
(1)
|
(493
|
)
|
|
—
|
|
|
(493
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||
Derivatives
|
952
|
|
|
(267
|
)
|
|
685
|
|
|
(1,215
|
)
|
|
379
|
|
|
(836
|
)
|
||||||
Amortization of prior service costs
|
214
|
|
|
(85
|
)
|
|
129
|
|
|
214
|
|
|
(86
|
)
|
|
128
|
|
||||||
Amortization of actuarial change
|
523
|
|
|
(208
|
)
|
|
315
|
|
|
608
|
|
|
(242
|
)
|
|
366
|
|
||||||
Other comprehensive income (loss)
|
$
|
(4,503
|
)
|
|
$
|
1,141
|
|
|
$
|
(3,362
|
)
|
|
$
|
13,096
|
|
|
$
|
(3,418
|
)
|
|
$
|
9,678
|
|
Comprehensive income
|
|
|
|
|
|
|
$
|
2,195
|
|
|
|
|
|
|
|
|
$
|
14,316
|
|
|
March 31,
2012 |
|
June 30,
2011 |
||||
(Amounts in Thousands)
|
|
|
|
||||
Foreign currency translation adjustments
|
$
|
2,752
|
|
|
$
|
7,750
|
|
Derivative loss
|
(3,991
|
)
|
|
(4,465
|
)
|
||
Postemployment benefits:
|
|
|
|
||||
Prior service costs
|
(507
|
)
|
|
(636
|
)
|
||
Net actuarial gain (loss)
|
2
|
|
|
(1,031
|
)
|
||
Accumulated other comprehensive income (loss)
|
$
|
(1,744
|
)
|
|
$
|
1,618
|
|
|
Three Months Ended
|
|
|
Nine Months Ended
|
|
||||||||||||||
|
March 31
|
|
|
March 31
|
|
||||||||||||||
(Amounts in Thousands)
|
2012
|
|
|
2011
|
|
|
2012
|
|
|
2011
|
|
||||||||
Net Sales:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Electronic Manufacturing Services
|
$
|
160,959
|
|
|
|
$
|
198,985
|
|
|
|
$
|
451,899
|
|
|
|
$
|
558,291
|
|
|
Furniture
|
123,455
|
|
|
|
115,481
|
|
|
|
400,054
|
|
|
|
361,483
|
|
|
||||
Consolidated
|
$
|
284,414
|
|
|
|
$
|
314,466
|
|
|
|
$
|
851,953
|
|
|
|
$
|
919,774
|
|
|
Net Income (Loss):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Electronic Manufacturing Services
|
$
|
3,303
|
|
|
|
$
|
3,151
|
|
|
|
$
|
2,515
|
|
|
|
$
|
2,794
|
|
|
Furniture
|
(842
|
)
|
|
|
(12
|
)
|
|
|
3,771
|
|
|
|
1,378
|
|
|
||||
Unallocated Corporate and Eliminations
|
45
|
|
|
|
167
|
|
|
|
(729
|
)
|
|
|
466
|
|
|
||||
Consolidated
|
$
|
2,506
|
|
(1)
|
|
$
|
3,306
|
|
(2)
|
|
$
|
5,557
|
|
(1)
|
|
$
|
4,638
|
|
(2)
|
(1)
|
Net Income (Loss) included after-tax restructuring charges, in thousands, of
$539
and
$1,497
in the
three and nine
months ended
March 31, 2012
, respectively. The EMS segment recorded, in the
three and nine
months ended
March 31, 2012
, in thousands,
$519
and
$1,450
, respectively, of after-tax restructuring charges. Unallocated Corporate and Eliminations recorded, in the
three and nine
months ended
March 31, 2012
, in thousands,
$20
and
$47
, respectively, of after-tax restructuring charges. The Furniture segment did not record restructuring during the
three and nine
months ended
March 31, 2012
. See
Note 6 - Restructuring Expense
of Notes to Condensed Consolidated Financial Statements for further discussion.
|
(2)
|
Net Income (Loss) included after-tax restructuring charges, in thousands, of
$40
and
$332
in the
three and nine
months ended
March 31, 2011
, respectively. The EMS segment recorded, in the
three and nine
months ended
March 31, 2011
, in thousands,
$19
and
$284
, respectively, of after-tax restructuring charges. Unallocated Corporate and Eliminations recorded, in the
three and nine
months ended
March 31, 2011
, in thousands,
$21
and
$48
, respectively, of after-tax restructuring charges. The Furniture segment did not record restructuring during the
three and nine
months ended
March 31, 2011
. See
Note 6 - Restructuring Expense
of Notes to Condensed Consolidated Financial Statements for further discussion.
|
(Amounts in Thousands)
|
March 31,
2012 |
|
June 30,
2011 |
||||
Total Assets:
|
|
|
|
||||
Electronic Manufacturing Services
|
$
|
354,419
|
|
|
$
|
377,067
|
|
Furniture
|
181,197
|
|
|
191,275
|
|
||
Unallocated Corporate and Eliminations
|
61,132
|
|
|
57,970
|
|
||
Consolidated
|
$
|
596,748
|
|
|
$
|
626,312
|
|
|
Nine Months Ended
|
||||||
|
March 31
|
||||||
(Amounts in Thousands)
|
2012
|
|
2011
|
||||
Product Warranty Liability at the beginning of the period
|
$
|
2,109
|
|
|
$
|
1,818
|
|
Additions to warranty accrual (including increases/decreases in estimates)
|
471
|
|
|
2,088
|
|
||
Settlements made (in cash or in kind)
|
(656
|
)
|
|
(1,747
|
)
|
||
Product Warranty Liability at the end of the period
|
$
|
1,924
|
|
|
$
|
2,159
|
|
•
|
The Company successfully completed the move of production from Longford, Ireland, into a former Poznan, Poland facility during the fiscal year 2009 second quarter.
|
•
|
Construction of a new, larger facility in Poland was completed in the fourth quarter of fiscal year 2009.
|
•
|
The Company sold the former Poland facility and land during fiscal year 2010 and recorded a $6.7 million pre-tax gain.
|
•
|
The former Poland facility was leased back until the transfer of the remaining production to the new facility was completed in fiscal year 2011.
|
•
|
The Company completed the consolidation of its EMS facility located in Wales, United Kingdom into the new facility. Production in Wales ceased and was transferred to the Poland facility in the second quarter of fiscal year 2012. The lease for the Wales facility terminated in the third quarter of fiscal year 2012.
|
Summary of All Plans
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
|
Accrued
June 30,
2011
(2)
|
|
|
Nine Months Ended March 31, 2012
|
|
|
|
Total Charges
Incurred Since Plan Announcement
|
|
Total Expected
Plan Costs
|
|||||||||||||||||||||
(Amounts in Thousands)
|
|
Amounts
Charged Cash
|
|
Amounts
Charged (Income)
Non-cash
|
|
Amounts Utilized/
Cash Paid
|
|
Adjustments
|
|
Accrued
March 31,
2012
(2)
|
|
|
|||||||||||||||||||
EMS Segment
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
FY 2011 Fremont Restructuring Plan
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Transition and Other Employee Costs
|
$
|
264
|
|
|
$
|
—
|
|
|
$
|
15
|
|
|
$
|
(236
|
)
|
|
$
|
(43
|
)
|
|
$
|
—
|
|
|
$
|
236
|
|
|
$
|
236
|
|
Plant Closure and Other Exit Costs
|
—
|
|
667
|
|
|
—
|
|
|
(340
|
)
|
|
—
|
|
|
327
|
|
|
687
|
|
|
750
|
|
|||||||||
Total
|
$
|
264
|
|
|
$
|
667
|
|
|
$
|
15
|
|
|
$
|
(576
|
)
|
|
$
|
(43
|
)
|
|
$
|
327
|
|
|
$
|
923
|
|
|
$
|
986
|
|
FY 2008 European Consolidation Plan
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
Transition and Other Employee Costs
|
$
|
7,694
|
|
|
$
|
930
|
|
|
$
|
—
|
|
|
$
|
(8,499
|
)
|
|
$
|
(125
|
)
|
(3)
|
$
|
—
|
|
|
$
|
20,824
|
|
|
$
|
20,824
|
|
Asset Write-downs (Gain on Sale)
|
—
|
|
|
—
|
|
|
(182
|
)
|
|
182
|
|
|
—
|
|
|
—
|
|
|
340
|
|
|
340
|
|
||||||||
Plant Closure and Other Exit Costs
|
—
|
|
|
1,022
|
|
|
|
|
|
(1,022
|
)
|
|
—
|
|
|
—
|
|
|
1,680
|
|
|
1,680
|
|
||||||||
Total
|
$
|
7,694
|
|
|
$
|
1,952
|
|
|
$
|
(182
|
)
|
|
$
|
(9,339
|
)
|
|
$
|
(125
|
)
|
|
$
|
—
|
|
|
$
|
22,844
|
|
|
$
|
22,844
|
|
Total EMS Segment
|
$
|
7,958
|
|
|
$
|
2,619
|
|
|
$
|
(167
|
)
|
|
$
|
(9,915
|
)
|
|
$
|
(168
|
)
|
|
$
|
327
|
|
|
$
|
23,767
|
|
|
$
|
23,830
|
|
Unallocated Corporate
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
Other Restructuring Plan
(1)
|
—
|
|
|
79
|
|
|
—
|
|
|
(79
|
)
|
|
—
|
|
|
—
|
|
|
844
|
|
|
956
|
|
||||||||
Consolidated Total of All Plans
|
$
|
7,958
|
|
|
$
|
2,698
|
|
|
$
|
(167
|
)
|
|
$
|
(9,994
|
)
|
|
$
|
(168
|
)
|
|
$
|
327
|
|
|
$
|
24,611
|
|
|
$
|
24,786
|
|
(1)
|
Other Restructuring Plan represents the Gaylord restructuring plan initiated in fiscal year 2007.
|
(2)
|
Accrued restructuring at
March 31, 2012
and
June 30, 2011
of
$0.3 million
and
$8.0 million
, respectively, was recorded in current liabilities.
|
(3)
|
The effect of changes in foreign currency exchange rates, primarily due to revaluation of the restructuring liability, is included in this amount. This currency translation adjustment is recorded in Accumulated Other Comprehensive Income (Loss), as a component of Share Owners' Equity.
|
•
|
Level 1: Unadjusted quoted prices in active markets for identical assets and liabilities.
|
•
|
Level 2: Observable inputs other than those included in level 1. For example, quoted prices for similar assets or liabilities in active markets or quoted prices for identical assets or liabilities in inactive markets.
|
•
|
Level 3: Unobservable inputs reflecting management's own assumptions about the inputs used in pricing the asset or liability.
|
Financial Instrument
|
|
Level
|
|
Valuation Technique/Inputs Used
|
Cash Equivalents
|
|
1
|
|
Market - Quoted market prices
|
Derivative Assets: Foreign exchange contracts
|
|
2
|
|
Market - Based on observable market inputs using standard calculations, such as time value, forward interest rate yield curves, and current spot rates, considering counterparty credit risk
|
Derivative Assets: Stock warrants
|
|
3
|
|
Market - Based on a Black-Scholes valuation model with the following inputs (level 3 input values indicated in parenthesis): risk-free interest rate (1.01%), historical stock price volatility (94.8%), expected term (5.2 years), and estimated stock price ($0.15)
Stock warrants are revalued and analyzed for reasonableness on a quarterly basis. The level 3 inputs used are the standard inputs used in the Black-Scholes model. Input values are based on publicly available information (Federal Reserve interest rates) and internally-developed information (historical stock price volatility of comparable investments, remaining expected term of warrants, and discounted cash flow calculation of underlying investment).
Significant increases (decreases) in the historical stock price volatility, expected life and estimated stock price inputs in isolation would result in a significantly higher (lower) fair value measurement. The inputs do not have any interrelationships.
|
Trading securities: Mutual funds held by nonqualified supplemental employee retirement plan
|
|
1
|
|
Market - Quoted market prices
|
Derivative Liabilities: Foreign exchange contracts
|
|
2
|
|
Market - Based on observable market inputs using standard calculations, such as time value, forward interest rate yield curves, and current spot rates adjusted for the Company's non-performance risk
|
|
March 31, 2012
|
||||||||||||||
(Amounts in Thousands)
|
Level 1
|
|
Level 2
|
|
Level 3
|
|
Total
|
||||||||
Assets
|
|
|
|
|
|
|
|
||||||||
Derivatives: Foreign exchange contracts
|
$
|
—
|
|
|
$
|
1,400
|
|
|
$
|
—
|
|
|
$
|
1,400
|
|
Derivatives: Stock warrants
|
—
|
|
|
—
|
|
|
1,373
|
|
|
1,373
|
|
||||
Trading Securities: Mutual funds held by nonqualified supplemental employee retirement plan
|
17,195
|
|
|
—
|
|
|
—
|
|
|
17,195
|
|
||||
Total assets at fair value
|
$
|
17,195
|
|
|
$
|
1,400
|
|
|
$
|
1,373
|
|
|
$
|
19,968
|
|
Liabilities
|
|
|
|
|
|
|
|
|
|
|
|
||||
Derivatives: Foreign exchange contracts
|
$
|
—
|
|
|
$
|
831
|
|
|
$
|
—
|
|
|
$
|
831
|
|
Total liabilities at fair value
|
$
|
—
|
|
|
$
|
831
|
|
|
$
|
—
|
|
|
$
|
831
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
June 30, 2011
|
||||||||||||||
(Amounts in Thousands)
|
Level 1
|
|
Level 2
|
|
Level 3
|
|
Total
|
||||||||
Assets
|
|
|
|
|
|
|
|
||||||||
Cash equivalents
|
$
|
32,021
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
32,021
|
|
Derivatives: Foreign exchange contracts
|
—
|
|
|
1,044
|
|
|
—
|
|
|
1,044
|
|
||||
Derivatives: Stock warrants
|
—
|
|
|
—
|
|
|
1,437
|
|
|
1,437
|
|
||||
Trading Securities: Mutual funds held by nonqualified supplemental employee retirement plan
|
16,138
|
|
|
—
|
|
|
—
|
|
|
16,138
|
|
||||
Total assets at fair value
|
$
|
48,159
|
|
|
$
|
1,044
|
|
|
$
|
1,437
|
|
|
$
|
50,640
|
|
Liabilities
|
|
|
|
|
|
|
|
|
|
|
|
||||
Derivatives: Foreign exchange contracts
|
$
|
—
|
|
|
$
|
1,684
|
|
|
$
|
—
|
|
|
$
|
1,684
|
|
Total liabilities at fair value
|
$
|
—
|
|
|
$
|
1,684
|
|
|
$
|
—
|
|
|
$
|
1,684
|
|
Financial Instrument
|
|
Level
|
|
Valuation Technique/Inputs Used
|
Notes receivable
|
|
2
|
|
Market - Price approximated based on the assumed collection of receivables in the normal course of business, taking into account the customer's non-performance risk
|
Non-marketable equity securities (cost-method investments, which carry shares at cost except in the event of impairment)
|
|
3
|
|
See explanation below regarding the method used to periodically estimate the fair value of cost-method investments
|
Long-term debt (carried at amortized cost)
|
|
3
|
|
Income - Price estimated using a discounted cash flow analysis based on quoted long-term debt market rates, taking into account the Company's non-performance risk
|
|
Asset Derivatives
|
|
Liability Derivatives
|
||||||||||||||||
(Amounts in Thousands)
|
|
Fair Value As of
|
|
|
|
Fair Value As of
|
|||||||||||||
|
Balance Sheet Location
|
|
March 31,
2012 |
|
June 30,
2011 |
|
Balance Sheet Location
|
|
March 31,
2012 |
|
June 30,
2011 |
||||||||
Derivatives designated as hedging instruments:
|
|
|
|
|
|
|
|
|
|
|
|||||||||
Foreign exchange contracts
|
Prepaid expenses and other current assets
|
|
$
|
874
|
|
|
$
|
644
|
|
|
Accrued expenses
|
|
$
|
803
|
|
|
$
|
415
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Derivatives not designated as hedging instruments:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
Foreign exchange contracts
|
Prepaid expenses and other current assets
|
|
526
|
|
|
400
|
|
|
Accrued expenses
|
|
28
|
|
|
1,269
|
|
||||
Stock warrants
|
Other assets (long-term)
|
|
1,373
|
|
|
1,437
|
|
|
|
|
|
|
|
|
|
||||
Total derivatives
|
|
|
$
|
2,773
|
|
|
$
|
2,481
|
|
|
|
|
$
|
831
|
|
|
$
|
1,684
|
|
|
|
|
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||
|
|
|
|
March 31
|
|
March 31
|
||||||||||||
(Amounts in Thousands)
|
|
|
|
2012
|
|
2011
|
|
2012
|
|
2011
|
||||||||
Amount of Pre-Tax Gain or (Loss) Recognized in Other Comprehensive Income (Loss) (OCI) on Derivatives (Effective Portion):
|
|
|
|
|
|
|
|
|
||||||||||
Foreign exchange contracts
|
|
|
|
$
|
1,697
|
|
|
$
|
(337
|
)
|
|
$
|
(503
|
)
|
|
$
|
839
|
|
|
|
|
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||
(Amounts in Thousands)
|
|
|
|
March 31
|
|
March 31
|
||||||||||||
Derivatives in Cash Flow Hedging Relationships
|
|
Location of Gain or (Loss)
|
|
2012
|
|
2011
|
|
2012
|
|
2011
|
||||||||
Amount of Pre-Tax Gain or (Loss) Reclassified from Accumulated OCI into Income (Effective Portion):
|
|
|
|
|
|
|
|
|
||||||||||
Foreign exchange contracts
|
|
Cost of Sales
|
|
$
|
(228
|
)
|
|
$
|
562
|
|
|
$
|
(1,061
|
)
|
|
$
|
1,296
|
|
Foreign exchange contracts
|
|
Non-operating income, net
|
|
(8
|
)
|
|
(157
|
)
|
|
109
|
|
|
(84
|
)
|
||||
Total
|
|
|
|
$
|
(236
|
)
|
|
$
|
405
|
|
|
$
|
(952
|
)
|
|
$
|
1,212
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
Amount of Pre-Tax Gain or (Loss) Reclassified from Accumulated OCI into Income (Ineffective Portion):
|
|
|
|
|
|
|
|
|
||||||||||
Foreign exchange contracts
|
|
Non-operating income, net
|
|
$
|
—
|
|
|
$
|
3
|
|
|
$
|
—
|
|
|
$
|
3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Derivatives Not Designated as Hedging Instruments
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Amount of Pre-Tax Gain or (Loss) Recognized in Income on Derivatives:
|
|
|
|
|
|
|
|
|
||||||||||
Foreign exchange contracts
|
|
Non-operating income, net
|
|
$
|
(454
|
)
|
|
$
|
(1,598
|
)
|
|
$
|
1,655
|
|
|
$
|
(3,761
|
)
|
Stock warrants
|
|
Non-operating income, net
|
|
(22
|
)
|
|
(5
|
)
|
|
(63
|
)
|
|
5
|
|
||||
Total
|
|
|
|
$
|
(476
|
)
|
|
$
|
(1,603
|
)
|
|
$
|
1,592
|
|
|
$
|
(3,756
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Total Derivative Pre-Tax Gain (Loss) Recognized in Income
|
|
$
|
(712
|
)
|
|
$
|
(1,195
|
)
|
|
$
|
640
|
|
|
$
|
(2,541
|
)
|
(Amounts in Thousands)
|
March 31
2012 |
|
June 30
2011 |
||||
SERP investment - current asset
|
$
|
6,041
|
|
|
$
|
5,604
|
|
SERP investment - other long-term asset
|
11,154
|
|
|
10,534
|
|
||
Total SERP investment
|
$
|
17,195
|
|
|
$
|
16,138
|
|
|
|
|
|
||||
SERP obligation - current liability
|
$
|
6,041
|
|
|
$
|
5,604
|
|
SERP obligation - other long-term liability
|
11,154
|
|
|
10,534
|
|
||
Total SERP obligation
|
$
|
17,195
|
|
|
$
|
16,138
|
|
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||
|
March 31
|
|
March 31
|
||||||||||||
(Amounts in Thousands)
|
2012
|
|
2011
|
|
2012
|
|
2011
|
||||||||
Service cost
|
$
|
199
|
|
|
$
|
227
|
|
|
$
|
604
|
|
|
$
|
711
|
|
Interest cost
|
49
|
|
|
65
|
|
|
150
|
|
|
203
|
|
||||
Amortization of prior service costs
|
71
|
|
|
71
|
|
|
214
|
|
|
214
|
|
||||
Amortization of actuarial change
|
20
|
|
|
183
|
|
|
523
|
|
|
608
|
|
||||
Net periodic benefit cost
|
$
|
339
|
|
|
$
|
546
|
|
|
$
|
1,491
|
|
|
$
|
1,736
|
|
Performance Shares
|
|
Quarter Awarded
|
|
Shares
|
|
Grant Date Fair Value
(4)
|
|||
Annual Performance Shares – Class A
(1)
|
|
1st Quarter
|
|
327,000
|
|
|
|
$5.45
|
|
Long-Term Performance Shares – Class A
(2)
|
|
1st Quarter
|
|
467,200
|
|
|
|
$5.45
|
|
|
|
|
|
|
|
|
|||
Unrestricted Shares
|
|
Quarter Awarded
|
|
Shares
|
|
Grant Date Fair Value
(4)
|
|||
Unrestricted Shares (Director Compensation) – Class B
(3)
|
|
2nd Quarter
|
|
14,687
|
|
|
|
$5.73
|
|
Unrestricted Shares – Class A
(3)
|
|
3rd Quarter
|
|
4,500
|
|
|
|
$6.40
|
|
Unrestricted Shares – Class B
(3)
|
|
3rd Quarter
|
|
3,000
|
|
|
|
$6.40
|
|
(1)
|
Annual performance shares were awarded to officers. Payouts will be based upon the fiscal year
2012
cash incentive payout percentages calculated under the Company's Profit Sharing Incentive Bonus Plan. The number of shares issued will be less than the maximum potential shares issuable if the maximum cash incentive payout percentages are not achieved. Annual performance shares vest after one year.
|
(2)
|
Long-term performance shares were awarded to officers and other key employees. Payouts will be based upon the cash incentive payout percentages calculated under the Company's Profit Sharing Incentive Bonus Plan. Long-term performance shares are based on five successive annual performance measurement periods, with each annual tranche having a grant date when economic profit tiers are established at the beginning of the applicable fiscal year and a vesting date at the end of each annual period. The number of shares issued will be less than the maximum potential shares issuable if the maximum cash incentive payout percentages are not achieved.
|
(3)
|
Unrestricted shares were awarded to non-employee members of the Board of Directors as compensation for director's fees as a result of directors' elections to receive unrestricted shares in lieu of cash payment. Director's fees are expensed over the period that directors earn the compensation.
Other unrestricted shares were awarded to officers as consideration for their service to the Company. Unrestricted shares do not have vesting periods, holding periods, restrictions on sale, or other restrictions.
|
(4)
|
The grant date fair value of performance shares is based on the stock price at the date of the award, reduced by the present value of dividends normally paid over the vesting period which are not payable on outstanding performance share awards. The grant date fair value shown for long-term performance shares is applicable to the first tranche only. The grant date fair value of the unrestricted shares was based on the stock price at the date of the award.
|
|
As of March 31, 2012
|
|
As of June 30, 2011
|
||||||||||||||||||||
(Amounts in Thousands)
|
Unpaid Balance
|
|
Related Allowance
|
|
Receivable Net of Allowance
|
|
Unpaid Balance
|
|
Related Allowance
|
|
Receivable Net of Allowance
|
||||||||||||
Note Receivable from Sale of Indiana Facility
|
$
|
1,390
|
|
|
$
|
—
|
|
|
$
|
1,390
|
|
|
$
|
1,334
|
|
|
$
|
—
|
|
|
$
|
1,334
|
|
Notes Receivable from an Electronics Engineering Services Firm
|
1,341
|
|
|
—
|
|
|
1,341
|
|
|
1,420
|
|
|
—
|
|
|
1,420
|
|
||||||
Total
|
$
|
2,731
|
|
|
$
|
—
|
|
|
$
|
2,731
|
|
|
$
|
2,754
|
|
|
$
|
—
|
|
|
$
|
2,754
|
|
•
|
While certain sectors are showing signs of economic recovery, the macroeconomic environment continues to reflect volatility and drive uncertainty as a result of significant fiscal problems. The impact is reflected in all of the Company's markets, which can disrupt business strategy, execution, and timing.
|
•
|
The nature of the EMS industry is such that the start-up of new programs to replace departing customers or expiring programs occurs frequently. As previously announced, the Company's sales to Bayer AG began to decline in the fourth quarter of fiscal year 2011 as the Company's primary manufacturing contract with Bayer AG expired. Margins on the Bayer AG product were generally lower than the Company's other EMS products. The Company continues to manufacture other products for Bayer AG. The success of the Company's EMS segment is dependent on the successful replacement of such customers or programs. Such changes usually occur gradually over time as old programs phase out of production while newer programs ramp up. The transition to new programs may temporarily reduce sales and increase operating costs,
resulting in a temporary decline in operating profit at the impacted business unit.
|
•
|
Commodity pricing has fluctuated significantly over the past several quarters. Inflation has moderated and does not appear to be a significant risk in the near-term. However, oil and fuel prices are putting upward pressure on inflation that may begin to impact costs early into the Company's fiscal year 2013. Mitigating the impact of raw material commodity pricing pressures and increasing prices for fuel and other freight costs, such as container rates on ocean vessels, continues to be an area of focus within the Company.
|
•
|
The Company will continue its focus on maintaining a strong financial position. Managing working capital in conjunction with fluctuating demand levels is key. In addition, the Company plans to continue to invest in capital expenditures prudently for projects in support of both organic growth and potential acquisitions that would enhance the Company's capabilities and diversification while providing an opportunity for growth and improved profitability.
|
•
|
Management continues to evaluate and monitor the implementation of the healthcare reform legislation that was signed into law in March 2010. This legislation is expected to increase the Company's healthcare and related administrative expenses as the provisions of the law become effective over the next couple of years.
|
•
|
Globalization continues to reshape not only the industries in which the Company operates but also its key customers and competitors.
|
•
|
The Company's employees throughout its business operations are an integral part of the Company's ability to compete successfully, and the stability of its management team is critical to long-term Share Owner value. The Company's career development and succession planning processes help to maintain stability in management.
|
|
Three Months Ended
|
|
Nine Months Ended
|
||||
|
March 31
|
|
March 31
|
||||
|
2012
|
|
2011
|
|
2012
|
|
2011
|
EMS segment net sales as % of total
|
57%
|
|
63%
|
|
53%
|
|
61%
|
Furniture segment net sales as % of total
|
43%
|
|
37%
|
|
47%
|
|
39%
|
|
At or for the
Three Months Ended
|
|
|
|
For the
Nine Months Ended |
|
|
||||||||||||||
|
March 31
|
|
|
|
March 31
|
|
|
||||||||||||||
(Amounts in Millions)
|
2012
|
|
2011
|
|
% Change
|
|
|
2012
|
|
2011
|
|
% Change
|
|||||||||
Net Sales
|
$
|
161.0
|
|
|
$
|
199.0
|
|
|
(19
|
)%
|
|
$
|
451.9
|
|
|
$
|
558.3
|
|
|
(19
|
)%
|
Operating Income
|
$
|
5.0
|
|
|
$
|
4.5
|
|
|
11
|
%
|
|
$
|
3.0
|
|
|
$
|
4.9
|
|
|
(39
|
)%
|
Operating Income %
|
3.1
|
%
|
|
2.3
|
%
|
|
|
|
0.7
|
%
|
|
0.9
|
%
|
|
|
||||||
Net Income
|
$
|
3.3
|
|
|
$
|
3.2
|
|
|
5
|
%
|
|
$
|
2.5
|
|
|
$
|
2.8
|
|
|
(10
|
)%
|
Restructuring Expense, net of tax
|
$
|
0.5
|
|
|
$
|
—
|
|
|
|
|
|
$
|
1.5
|
|
|
$
|
0.3
|
|
|
|
|
Open Orders
|
$
|
154.1
|
|
|
$
|
175.4
|
|
|
(12
|
)%
|
|
|
|
|
|
|
|
Three Months Ended
|
|
Nine Months Ended
|
||||
|
March 31
|
|
March 31
|
||||
|
2012
|
|
2011
|
|
2012
|
|
2011
|
Bayer AG affiliated sales as a percent of consolidated net sales
|
—%
|
|
15%
|
|
—%
|
|
14%
|
Bayer AG affiliated sales as a percent of EMS segment net sales
|
—%
|
|
23%
|
|
1%
|
|
22%
|
|
At or for the
Three Months Ended
|
|
|
|
For the
Nine Months Ended |
|
|
||||||||||||||
|
March 31
|
|
|
|
March 31
|
|
|
||||||||||||||
(Amounts in Millions)
|
2012
|
|
2011
|
|
% Change
|
|
2012
|
|
2011
|
|
% Change
|
||||||||||
Net Sales
|
$
|
123.5
|
|
|
$
|
115.5
|
|
|
7
|
%
|
|
$
|
400.1
|
|
|
$
|
361.5
|
|
|
11
|
%
|
Operating Income (Loss)
|
$
|
(1.2
|
)
|
|
$
|
0.2
|
|
|
(669
|
)%
|
|
$
|
6.0
|
|
|
$
|
2.6
|
|
|
136
|
%
|
Operating Income (Loss) %
|
(1.0
|
)%
|
|
0.2
|
%
|
|
|
|
1.5
|
%
|
|
0.7
|
%
|
|
|
||||||
Net Income (Loss)
|
$
|
(0.8
|
)
|
|
$
|
—
|
|
|
|
|
|
$
|
3.8
|
|
|
$
|
1.4
|
|
|
174
|
%
|
Open Orders
|
$
|
73.3
|
|
|
$
|
76.5
|
|
|
(4
|
)%
|
|
|
|
|
|
|
Covenant
|
|
At or For the
Period Ended
March 31, 2012
|
|
Limit As
Specified in
Credit Agreement
|
|
Excess
|
||||||
Minimum Net Worth
|
|
$
|
384,749,000
|
|
|
$
|
362,000,000
|
|
|
$
|
22,749,000
|
|
Interest Coverage Ratio
|
|
309
|
|
|
3.0
|
|
|
306
|
|
•
|
Sales returns and allowances - At the time revenue is recognized certain provisions may also be recorded, including a provision for returns and allowances, which involve estimates based on current discussions with applicable customers, historical experience with a particular customer and/or product, and other relevant factors. As such, these factors may change over time causing the provisions to be adjusted accordingly. At
March 31, 2012
and
June 30, 2011
, the reserve for returns and allowances was
$2.7 million
and
$2.1 million
, respectively. The returns and allowances reserve approximated 1% to 2% of gross trade receivables during the two-year period preceding
March 31, 2012
.
|
•
|
Allowance for doubtful accounts - Allowance for doubtful accounts is generally based on a percentage of aged accounts receivable, where the percentage increases as the accounts receivable become older. However, management judgment is utilized in the final determination of the allowance based on several factors including specific analysis of a customer's credit worthiness, changes in a customer's payment history, historical bad debt experience, and general economic and market trends. The allowance for doubtful accounts at
March 31, 2012
and at
June 30, 2011
was
$1.2 million
and
$1.4 million
, respectively. During the two-year period preceding
March 31, 2012
, this reserve had approximated 1% of gross trade accounts receivable.
|
(a)
|
Evaluation of disclosure controls and procedures.
|
(b)
|
Changes in internal control over financial reporting.
|
3(a)
|
Amended and restated Articles of Incorporation of the Company (Incorporated by reference to Exhibit 3(a) to the Company's Form 10-K for the fiscal year ended June 30, 2007)
|
3(b)
|
Restated By-laws of the Company (Incorporated by reference to Exhibit 3(b) to the Company's Form 8-K filed October 23, 2009)
|
10
|
Summary of Director and Named Executive Officer Compensation
|
11
|
Computation of Earnings Per Share
|
31.1
|
Certification filed by Chief Executive Officer pursuant to Rule 13a-14(a)/15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
|
31.2
|
Certification filed by Chief Financial Officer pursuant to Rule 13a-14(a)/15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
|
32.1
|
Certification furnished by the Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
|
32.2
|
Certification furnished by the Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
|
101.INS
|
XBRL Instance Document *
|
101.SCH
|
XBRL Taxonomy Extension Schema Document *
|
101.CAL
|
XBRL Taxonomy Extension Calculation Linkbase Document *
|
101.DEF
|
XBRL Taxonomy Extension Definition Linkbase Document *
|
101.LAB
|
XBRL Taxonomy Extension Label Linkbase Document *
|
101.PRE
|
XBRL Taxonomy Extension Presentation Linkbase Document *
|
|
|
KIMBALL INTERNATIONAL, INC.
|
|
|
|
|
By:
|
/s/ JAMES C. THYEN
|
|
|
James C. Thyen
President,
Chief Executive Officer
|
|
|
May 3, 2012
|
|
|
|
|
|
|
|
By:
|
/s/ ROBERT F. SCHNEIDER
|
|
|
Robert F. Schneider
Executive Vice President,
Chief Financial Officer
|
|
|
May 3, 2012
|
Exhibit No.
|
|
Description
|
3(a)
|
|
Amended and restated Articles of Incorporation of the Company (Incorporated by reference to Exhibit 3(a) to the Company's Form 10-K for the fiscal year ended June 30, 2007)
|
3(b)
|
|
Restated By-laws of the Company (Incorporated by reference to Exhibit 3(b) to the Company's Form 8-K filed October 23, 2009)
|
10
|
|
Summary of Director and Named Executive Officer Compensation
|
11
|
|
Computation of Earnings Per Share
|
31.1
|
|
Certification filed by Chief Executive Officer pursuant to Rule 13a-14(a)/15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
|
31.2
|
|
Certification filed by Chief Financial Officer pursuant to Rule 13a-14(a)/15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
|
32.1
|
|
Certification furnished by the Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
|
32.2
|
|
Certification furnished by the Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
|
101.INS
|
|
XBRL Instance Document *
|
101.SCH
|
|
XBRL Taxonomy Extension Schema Document *
|
101.CAL
|
|
XBRL Taxonomy Extension Calculation Linkbase Document *
|
101.DEF
|
|
XBRL Taxonomy Extension Definition Linkbase Document *
|
101.LAB
|
|
XBRL Taxonomy Extension Label Linkbase Document *
|
101.PRE
|
|
XBRL Taxonomy Extension Presentation Linkbase Document *
|
|
|
* These interactive data files shall not be deemed filed for purposes of Section 11 or 12 of the Securities Act of 1933 or Section 18 of the Securities Exchange Act of 1934 or otherwise subject to liability under those sections.
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
---|
DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
---|
No information found
No Customers Found
Price
Yield
Owner | Position | Direct Shares | Indirect Shares |
---|